Author:
Kitao Tomoka,Shiga Tohru,Hirata Kenji,Sekizawa Mitsunori,Takei Toshiki,Yamashiro Katsushige,Tamaki Nagara
Publisher
Springer Science and Business Media LLC
Subject
Radiology Nuclear Medicine and imaging,General Medicine
Reference33 articles.
1. Ha SC, Oh JS, Roh J-L, Moon H, Kim JS, Cho K-J, et al. Pretreatment tumor SUVmax predicts disease-specific and overall survival in patients with head and neck soft tissue sarcoma. Eur J Nucl Med Mol Imaging. 2017;44:33–40.
2. Liu C-YC-L, Yen C-C, Chen W-M, Chen T-H, Chen PC-H, Wu H-TH, et al. Soft tissue sarcoma of extremities: the prognostic significance of adequate surgical margins in primary operation and reoperation after recurrence. Ann Surg Oncol. 2010;17:2102–11.
3. Been LB, Suurmeijer AJH, Elsinga PH, Jager PL, van Ginkel RJ, Hoekstra HJ. 18F-Fluorodeoxythymidine PET for evaluating the response to hyperthermic isolated limb perfusion for locally advanced soft-tissue sarcomas. J Nucl Med. 2007;48:367–72.
4. Ghigi G, Micera R, Maffione AM, Castellucci P, Cammelli S, Ammendolia I, et al. 11C-methione vs. 18F-FDG PET in soft tissue sarcoma patients treated with neoadjuvant therapy: preliminary results. In Vivo. 2009;23(1):105–10.
5. Kao CH, Lin SC, Hsieh TC, Yen KY, Yang SN, Wang YC, et al. Use of pretreatment metabolic tumour volumes to predict the outcome of pharyngeal cancer treated by definitive radiotherapy. Eur J Nucl Med Mol Imaging. 2012;39:1297–305.
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献